Review article · 2008 · Open access
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
American Journal of Psychiatry, 166(2), 152–163 · Published 17 November 2008 · DOI 10.1176/appi.ajp.2008.08030368
In brief
“A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia” is a 2008 review article by Stefan Leucht and 8 co-authors, published in American Journal of Psychiatry. OpenAlex counts 550 citations as of 20 November 2026, which puts it in the top 2% of works published in 2008 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Omeka S (Universidad de La Frontera).
- Citations
- 550
- Most cited in
- 2017 (31)
- Field-weighted impact
- 6.15
- References
- 33
- Authors
- 9
Abstract
OBJECTIVE: Whether there are differences in efficacy among second-generation antipsychotics in the treatment of schizophrenia is a matter of heated debate. The authors conducted a systematic review and meta-analysis of blinded studies comparing second-generation antipsychotics head-to-head. METHOD: Searches of the Cochrane Schizophrenia Group's register (May 2007) and MEDLINE (September 2007) were conducted for randomized, blinded studies comparing two or more of nine second-generation antipsychotics in the treatment of schizophrenia. All data were extracted by at least three reviewers independently. The primary outcome measure was change in total score on the Positive and Negative Syndrome Scale; secondary outcome measures were positive and negative symptom subscores and rate of dropout due to inefficacy. The results were combined in a meta-analysis. Various sensitivity analyses and metaregressions were used to examine bias. RESULTS: The analysis included 78 studies with 167 relevant arms and 13,558 participants. Olanzapine proved superior to aripiprazole, quetiapine, risperidone, and ziprasidone. Risperidone was more efficacious than quetiapine and ziprasidone. Clozapine proved superior to zotepine and, in doses >400 mg/day, to risperidone. These differences were due to improvement in positive symptoms rather than negative symptoms. The results were rather robust with regard to the effects of industry sponsorship, study quality, dosages, and trial duration. CONCLUSIONS: The findings suggest that some second-generation antipsychotics may be somewhat more efficacious than others, but the limitations of meta-analysis must be considered. In tailoring drug treatment to the individual patient, small efficacy superiorities must be weighed against large differences in side effects and cost.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Leucht, S., Komossa, K., Rummel‐Kluge, C., Corves, C., Hunger, H., Schmid, F., Lobos, C. A., Schwarz, S., & Davis, J. M. (2008). A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia. American Journal of Psychiatry, 166(2), 152–163. https://doi.org/10.1176/appi.ajp.2008.08030368
MLA 9
Leucht, Stefan, et al. “A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia.” American Journal of Psychiatry, vol. 166, no. 2, 2008, pp. 152–163. https://doi.org/10.1176/appi.ajp.2008.08030368.
Chicago
Leucht, Stefan, Katja Komossa, Christine Rummel‐Kluge, Caroline Corves, Heike Hunger, Franziska Schmid, Claudia Asenjo Lobos, Sandra Schwarz, and John M. Davis. 2008. “A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia.” American Journal of Psychiatry 166 (2): 152–163. https://doi.org/10.1176/appi.ajp.2008.08030368.
Harvard
Leucht, S. et al. (2008) ‘A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia’, American Journal of Psychiatry, 166(2), pp. 152–163. doi:10.1176/appi.ajp.2008.08030368.
IEEE
S. Leucht et al., “A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia,” American Journal of Psychiatry, vol. 166, no. 2, pp. 152–163, 2008, doi: 10.1176/appi.ajp.2008.08030368.
BibTeX
@article{leucht2008meta,
title = {{A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia}},
author = {Leucht, Stefan and Komossa, Katja and Rummel‐Kluge, Christine and Corves, Caroline and Hunger, Heike and Schmid, Franziska and Lobos, Claudia Asenjo and Schwarz, Sandra and Davis, John M.},
journal = {American Journal of Psychiatry},
year = {2008},
volume = {166},
number = {2},
pages = {152--163},
doi = {10.1176/appi.ajp.2008.08030368},
url = {https://doi.org/10.1176/appi.ajp.2008.08030368}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 31 | |
| 2018 | 27 | |
| 2019 | 23 | |
| 2020 | 22 | |
| 2021 | 14 | |
| 2022 | 12 | |
| 2023 | 14 | |
| 2024 | 13 | |
| 2025 | 7 | |
| 2026 | 9 |
Its field-weighted citation impact is 6.15: it has been cited 6.15 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- atypical antipsychotics
- schizophrenia
- antipsychotic efficacy
- olanzapine
- risperidone
- clozapine
- quetiapine
- ziprasidone
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Leucht, S., Komossa, K., Rummel‐Kluge, C., Corves, C., Hunger, H., Schmid, F., Lobos, C. A., Schwarz, S., & Davis, J. M. (2008). A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia. American Journal of Psychiatry, 166(2), 152–163. https://doi.org/10.1176/appi.ajp.2008.08030368
How many times has this paper been cited?
550 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Omeka S (Universidad de La Frontera): sign in and open the full text from this page.
Who wrote this paper?
Stefan Leucht, Katja Komossa, Christine Rummel‐Kluge, Caroline Corves, Heike Hunger, Franziska Schmid, Claudia Asenjo Lobos, Sandra Schwarz, John M. Davis.
What is the DOI of this paper?
10.1176/appi.ajp.2008.08030368, permanently at https://doi.org/10.1176/appi.ajp.2008.08030368. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.